Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease "Polypill"


Phase 2 Results

Summary of Purpose

Cardiovascular is a major cause of mortality in Iran, accounting for 45.7% of deaths. In Golestan (North Eastern Iran) preliminary findings from follow-up of the Golestan Cohort are consistent with national figures: with 45% (at least 22 of 48 deaths) of all deaths attributed to cardiovascular events. Cardiovascular diseases will become an increasing problem as the Iranian population ages. In 2003 Law and...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 September 2009.

1 Nov 2006 1 Jan 2008 1 Jun 2008 1 Jul 2008 1 Sep 2009 13 Apr 2009
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available